These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 27094810)

  • 1. Cause and consequences of the activated type I interferon system in SLE.
    Eloranta ML; Rönnblom L
    J Mol Med (Berl); 2016 Oct; 94(10):1103-1110. PubMed ID: 27094810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus.
    Luo S; Wang Y; Zhao M; Lu Q
    Int Immunopharmacol; 2016 Nov; 40():542-549. PubMed ID: 27769023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus and the type I interferon system.
    Rönnblom L; Alm GV
    Arthritis Res Ther; 2003; 5(2):68-75. PubMed ID: 12718746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interferons in SLE.
    Bengtsson AA; Rönnblom L
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):415-428. PubMed ID: 29224681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferon blockade in systemic lupus erythematosus: where do we stand?
    Lauwerys BR; Ducreux J; Houssiau FA
    Rheumatology (Oxford); 2014 Aug; 53(8):1369-76. PubMed ID: 24344319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Lupus Erythematosus--A Disease with A Dysregulated Type I Interferon System.
    Hagberg N; Rönnblom L
    Scand J Immunol; 2015 Sep; 82(3):199-207. PubMed ID: 26099519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A compass that points to lupus: genetic studies on type I interferon pathway.
    Kyogoku C; Tsuchiya N
    Genes Immun; 2007 Sep; 8(6):445-55. PubMed ID: 17581625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesis.
    Matta B; Barnes BJ
    Cytokine; 2020 Aug; 132():154731. PubMed ID: 31130331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferon in systemic lupus erythematosus.
    Crow MK
    Curr Top Microbiol Immunol; 2007; 316():359-86. PubMed ID: 17969456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I interferon signature in systemic lupus erythematosus.
    Bezalel S; Guri KM; Elbirt D; Asher I; Sthoeger ZM
    Isr Med Assoc J; 2014 Apr; 16(4):246-9. PubMed ID: 24834763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated T cells enhance interferon-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes.
    Leonard D; Eloranta ML; Hagberg N; Berggren O; Tandre K; Alm G; Rönnblom L
    Ann Rheum Dis; 2016 Sep; 75(9):1728-34. PubMed ID: 26493814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The innate immune system in SLE: type I interferons and dendritic cells.
    Rönnblom L; Pascual V
    Lupus; 2008 May; 17(5):394-9. PubMed ID: 18490415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.
    Kim JM; Park SH; Kim HY; Kwok SK
    Int J Mol Sci; 2015 Jun; 16(6):14158-70. PubMed ID: 26110387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I interferon and systemic lupus erythematosus.
    Elkon KB; Stone VV
    J Interferon Cytokine Res; 2011 Nov; 31(11):803-12. PubMed ID: 21859344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-interferon alpha treatment in SLE.
    Kirou KA; Gkrouzman E
    Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic identification of novel SLE related autoantibodies responsible for type I IFN production in human plasmacytoid dendritic cells.
    Kassim SH; Jordan J; Schreiter J; Adhikarakunnathu S; Baribaud F; San Mateo L
    Cell Immunol; 2013; 284(1-2):119-28. PubMed ID: 23973875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.
    Gallucci S; Meka S; Gamero AM
    Cytokine; 2021 Oct; 146():155633. PubMed ID: 34340046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.